3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
GENETIC: TdT-mediated dUTP nick end labeling assay
OTHER: 3'-deoxy-3'-[18F]fluorothymidine
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
RADIATION: fludeoxyglucose F 18
RADIATION: radiation therapy

Sponsor

Mayo Clinic

Collaborators

[object Object]